Foster City, CA, United States of America

Ganesh A Kolumam

USPTO Granted Patents = 4 


Average Co-Inventor Count = 9.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2016)
  • Foster City, CA (US) (2020 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ganesh A Kolumam: Innovator in Cardiovascular Treatments

Introduction

Ganesh A Kolumam is a prominent inventor based in Foster City, CA (US). He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for cardiovascular conditions. With a total of 4 patents to his name, Kolumam's work is paving the way for new therapeutic approaches.

Latest Patents

Kolumam's latest patents focus on methods for preventing or treating cardiovascular conditions using IL-22 Fc fusion proteins. The inventions relate to IL-22 polypeptides, IL-22 Fc fusion proteins, and IL-22 agonists. These compositions are designed for the treatment of various diseases. Additionally, the patents include pharmaceutical compositions of IL-22 Fc fusion proteins, emphasizing the importance of IL-22 receptor-associated reagents and their methods of use.

Career Highlights

Ganesh A Kolumam is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to focus on groundbreaking research that addresses critical health issues.

Collaborations

Kolumam has collaborated with notable colleagues, including Justin M Scheer and Wenjun Ouyang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Ganesh A Kolumam is a distinguished inventor whose work in cardiovascular treatments is making a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…